Otsuka Egypt
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- MUCOSTA film-coated tablet 100 mg
- B01 - Agentes antitrombóticos
- PLETAAL tablet 100 mg
- PLETAAL tablet 50 mg
- B05 - Sustitutos de sangre y soluciones para perfusión
- AMINOLEBA solution for infusion
- AMIPAREN solution for infusion 10%
- DEXTROSE IN RINGER solution for infusion 5%
- DEXTROSE IN RINGERS SOLUTION OTSUKA solution for infusion
- DEXTROSE OTSUKA solution for infusion 25 g/250 ml
- DEXTROSE OTSUKA solution for infusion 40%
- DEXTROSE OTSUKA solution for infusion 50%
- DEXTROSE SODIUM CHLORIDE OTSUKA solution for infusion 10%+ 0.9%
- DEXTROSE SODIUM CHLORIDE OTSUKA solution for infusion 5%+ 0.45%
- DEXTROSE SODIUM CHLORIDE OTSUKA solution for infusion 5%+ 0.9%
- GLUCOSE EL NASR solution for infusion 5%
- GLUCOSE OTSUKA solution for infusion 10%
- GLUCOSE OTSUKA solution for infusion 5%
- HAEMODIALYSIS FORMULA 1 solution for haemodialysis
- KIDMIN solution for haemodialysis
- LACTATED RINGERS OTSUKA solution for infusion
- MANNITOL BP 2003 solution for infusion 10%
- MANNITOL BP 2003 solution for infusion 20%
- NEOMAINT solution for infusion
- PAN AMIN SG solution for infusion
- POTASSIUM CHLORIDE solution for infusion 15%
- RINGER ACETATE OTSUKA solution for infusion
- RINGERS INJECTION OTSUKA solution for infusion
- SODIUM BICARBONATE BP88 solution for infusion 8.4%
- SODIUM CHLORIDE BP2001 solution for infusion 0.9%
- SODIUM CHLORIDE BP2003 solution for infusion 0.45%
- SODIUM CHLORIDE BP2003 solution for infusion 3%
- SODIUM CHLORIDE BP88 solution for infusion 10%
- SODIUM LACTATE USP27 solution for infusion 1.87%(1/6M)
- N05 - Psicolépticos
- ABILIFY tablet 10 mg
- ABILIFY tablet 15 mg